Clinical Applications of Proton MR Spectroscopy in Oncology

Proton magnetic resonance spectroscopy (H1-MRS) has been increasingly receiving more attention from radiologists, neurosurgeons, radiation and medical oncologists in the “in situ” clinical evaluation of human tumors. The utilization of H1-MRS, especially in human brain tumors, coupled to both routine magnetic resonance imaging (MRI) and functional MRI techniques provides greater information concerning tumor grading and extension and characterization of the normal surrounding tissue than what is possible with any other imaging technique alone. In this paper, we will review the current status of proton MR spectroscopy with emphasis on its clinical utility to diagnose tumors, its utility in planning surgical and radiation therapy interventions, and in its use in monitoring tumor treatment.

[1]  W. Hall,et al.  Preliminary assessment of turbo spectroscopic imaging for targeting in brain biopsy. , 2001, AJNR. American journal of neuroradiology.

[2]  D J Jenden,et al.  In vivo 1H MRS choline: correlation with in vitro chemistry/histology. , 1996, Life sciences.

[3]  L Verhey,et al.  Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. , 2001, AJNR. American journal of neuroradiology.

[4]  M. Castillo,et al.  Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders. , 1998, Magnetic resonance imaging clinics of North America.

[5]  K. Uğurbil,et al.  Resolution improvements in in vivo 1H NMR spectra with increased magnetic field strength. , 1998, Journal of magnetic resonance.

[6]  C E Mountford,et al.  Proton magnetic resonance and human thyroid neoplasia. I: Discrimination between benign and malignant neoplasms. , 1994, The American journal of medicine.

[7]  L. G. Astrakas,et al.  Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment , 2001, Neuroradiology.

[8]  A. Bizzi,et al.  Response of non-Hodgkin lymphoma to radiation therapy: early and long-term assessment with H-1 MR spectroscopic imaging. , 1995, Radiology.

[9]  F Lazeyras,et al.  Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. , 1996, AJR. American journal of roentgenology.

[10]  J A Frank,et al.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.

[11]  R. Tanaka,et al.  Magnetic resonance imaging and histopathology of cerebral gliomas , 2004, Neuroradiology.

[12]  L. Kwock,et al.  Localized MR spectroscopy: basic principles. , 1998, Neuroimaging clinics of North America.

[13]  W. Reddick,et al.  Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. , 1996, International journal of radiation oncology, biology, physics.

[14]  L Verhey,et al.  A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. , 2000, Neurosurgery.

[15]  I. Gribbestad,et al.  Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy , 1999, Journal of magnetic resonance imaging : JMRI.

[16]  M. Castillo,et al.  Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors. , 1999, Topics in magnetic resonance imaging : TMRI.

[17]  R. Somorjai,et al.  Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis , 1997, Magnetic resonance in medicine.

[18]  W P Dillon,et al.  Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. , 2001, AJNR. American journal of neuroradiology.

[19]  Ian C. P. Smith,et al.  1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue , 1994, NMR in biomedicine.

[20]  An efficient chemical shift imaging scheme for magnetic resonance‐guided neurosurgery , 2001, Journal of magnetic resonance imaging : JMRI.

[21]  H. Shimizu,et al.  Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. , 2000, AJNR. American journal of neuroradiology.

[22]  K. Isselbacher.  Increased uptake of amino acids and 2-deoxy-D-glucose by virus-transformed cells in culture. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Frahm,et al.  Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. , 1999, AJNR. American journal of neuroradiology.

[24]  Peter Russell,et al.  Computerized Consensus Diagnosis: A Classification Strategy for the Robust Analysis of MR Spectra. I. Application to 1H Spectra of Thyroid Neoplasms , 1995, Magnetic resonance in medicine.

[25]  C. Mountford,et al.  Assessment of human colorectal biopsies by 1H MRS: Correlation with histopathology , 1993, Magnetic resonance in medicine.

[26]  T. Chenevert,et al.  In Vivo Magnetic Resonance Imaging and Spectroscopy: Application to Brain Tumors , 1997 .

[27]  J K Smith,et al.  Correlation of myo-inositol levels and grading of cerebral astrocytomas. , 2000, AJNR. American journal of neuroradiology.

[28]  T. Ng,et al.  Therapeutic response of breast carcinoma monitored by 31P MRS in situ , 1989, Magnetic resonance in medicine.

[29]  J A Sorenson,et al.  Localized 2D J‐resolved H MR spectroscopy of human brain tumors in vivo , 1996, Journal of magnetic resonance imaging : JMRI.

[30]  W. Mackinnon,et al.  Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. , 1997, Radiology.

[31]  M. Castillo,et al.  Radiologic-pathologic correlation: intracranial astrocytoma. , 1992, AJNR. American journal of neuroradiology.

[32]  R. Sauter,et al.  Intratumoral lipids in 1H MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial. , 1996, Anticancer research.

[33]  S. Zeisel.  Choline. A nutrient that is involved in the regulation of cell proliferation, cell death, and cell transformation. , 1996, Advances in experimental medicine and biology.

[34]  J. Griffiths,et al.  19F MRS studies of fluoropyrimidine chemotherapy. A review , 1989, NMR in biomedicine.

[35]  Yasushi Ishii,et al.  Alterations of lactate (+lipid) concentration in brain tumors with in vivo hydrogen magnetic resonance spectroscopy during radiotherapy. , 1997, Investigative radiology.

[36]  W. Mackinnon,et al.  Fucose in 1H COSY spectra of plasma membrane fragments shed from human malignant colorectal cells , 1991, Magnetic resonance in medicine.

[37]  R. London.  13C labeling in studies of metabolic regulation , 1988 .

[38]  K. Muller,et al.  Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. , 1997, AJNR. American journal of neuroradiology.

[39]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[40]  S. Holtås,et al.  Proton MR spectroscopy in clinical routine , 2001, Journal of magnetic resonance imaging : JMRI.

[41]  D. Kondziolka,et al.  Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. , 1997, Neurosurgery.

[42]  M. Oudkerk,et al.  Correlation between choline level and Gd‐DTPA enhancement in patients with brain metastases of mammary carcinoma , 1994, Magnetic resonance in medicine.

[43]  M. Weiner,et al.  Phosphorus-31 MR spectroscopic imaging (MRSI) of normal and pathological human brains. , 1992, Magnetic resonance imaging.

[44]  N Sailasuta,et al.  Single‐voxel oversampled J‐resolved spectroscopy of in vivo human prostate tissue , 2001, Magnetic resonance in medicine.

[45]  V. Haughton,et al.  Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm. , 1998, AJNR. American journal of neuroradiology.

[46]  J. K. Smith,et al.  Effects of contrast material on single-volume proton MR spectroscopy. , 2000, AJNR. American journal of neuroradiology.

[47]  Makoto Ochi,et al.  Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy , 2001, European Radiology.

[48]  Carolyn E. Mountford,et al.  The Use of Proton MR in Cancer Pathology , 1993 .

[49]  James R. Allen,et al.  In Vivo Proton (H1) Magnetic Resonance Spectroscopy for Cervical Carcinoma , 2001, American journal of clinical oncology.

[50]  N. Debruhl,et al.  Volume‐localized two‐dimensional correlated magnetic resonance spectroscopy of human breast cancer , 2001, Journal of magnetic resonance imaging : JMRI.